FINHUB Insights

LH · Q1 FY26 · Mar 31, 2026

Labcorp Q1 FY26: where the revenue came from and where it went

Labcorp Q1 FY26: revenue $3.5B (+6% year over year). Net profit $0.3B. Largest cohort Diagnostics $2.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 31, 2026
Reported
May 4, 2026 10-Q
Sankey diagram of Labcorp's income statement for Q1 FY26: revenue of $3.5 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.5B +6% year over year
Gross profit$1B 29% margin
Operating profit$0.4B 11% margin
Net profit$0.3B 8% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 3.5 100% +6%
Diagnostics 2.8 80% +5%
Biopharma Laboratory 0.8 23% +8%
Cost of revenue−2.571%
Gross profit129% margin+0pp
SG&A−0.616%−1pp
Other−0.12%+0pp
Operating profit0.411% margin+1pp
Interest & other costs−0.1
Net profit0.38%+1pp
Filing on EDGAR More quarters of LH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters